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Huang Yan-Hong*, Li Jing, Luan Hong, Huang Shan-Shan, Li Yan and Li JuAbstract
Background: Alcohol consumption has been inconsistently associated with the risk of ovarian cancer. The purpose
of this study was to summarize the data from prospective cohort studies on the relationship between alcohol
consumption and ovarian cancer using a meta-analytic approach.
Methods: We performed electronic searches of PubMed, Embase, and the Cochrane Library in May 2014 to identify
studies that examined the effects of alcohol consumption on the incidence of ovarian cancer. Only prospective
cohort studies that reported effect estimates about the incidence of ovarian cancer with 95% confidence intervals
(CIs) of alcohol intake were included.
Results: Collectively, we included 13 prospective studies that reported on data from 1,996,841 individuals and
included 5,857 cases of ovarian cancer. Alcohol consumption had little to no effect on ovarian cancer incidence
when compared to non-drinkers (risk ratio [RR], 1.03; 95% CI, 0.96–1.10; P = 0.473). Similarly, low (RR, 0.96; 95% CI,
0.93–1.00; P = 0.059), moderate (RR, 1.08; 95% CI, 0.92–1.27; P = 0.333), and heavy (RR, 0.99; 95% CI, 0.88–1.12;
P = 0.904) alcohol consumption was not associated with the risk of ovarian cancer. Furthermore, subgroup analyses
suggested that low alcohol intake was associated with a reduced risk of ovarian cancer whereas heavy alcohol intake
was associated with an increased risk of ovarian cancer in multiple subpopulations.
Conclusions: Our study suggests that alcohol intake is not associated with an increased risk of ovarian cancer.
Subgroup analyses indicated that alcohol consumption might be associated with the risk of ovarian cancer in
specific population or in studies with specific characteristics.
Keywords: Alcohol intake, Ovarian cancer, Meta-analysisBackground
Alcohol is a commonly consumed beverage that has
both favourable and adverse effects on disease morbidity
and mortality [1]. Previous meta-analyses have shown
that light-to-moderate alcohol consumption is associated
with a decreased risk of thyroid cancer [2], Hodgkin
lymphoma [3], endometrial cancer [4], and renal cell
cancer [5], but it has no significant effects on the risk of
breast [6], bladder [7], pancreatic [8], gastric [9], and
lung [10] cancers. Additionally, some studies have sug-
gested that heavy alcohol consumption is associated with
an increased the risk of gastric, pancreatic, and breast* Correspondence: huangyanhongshen@126.com
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unless otherwise stated.cancers [8,9,11-13]. However, concerns have been raised
regarding the accompanied risk of ovarian cancer, which
has not been confirmed by previous studies.
The association between alcohol consumption and an
increased risk of ovarian cancer was first revealed in the
Breast Cancer Detection Demonstration Project [14].
More recently, the risk of ovarian cancer was found to
be 47% higher in subjects with moderate alcohol intake
(15–30 g/day) in a U.S. cohort [15]. A collaborative ana-
lysis of 23 case control studies, three cohort studies, and
one pooled analysis did not support an association be-
tween alcohol consumption and ovarian cancer risk [16].
However, the conclusions were not consistent between
studies, and the data regarding the association between
alcohol consumption and ovarian cancer morbidity wereral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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formed a systematic review and meta-analysis of cohort
studies to evaluate the association between alcohol in-
take and the incidence of ovarian cancer.
Methods
Data sources, search strategy, and selection criteria
This review was conducted and reported according to
the Preferred Reporting Items for Systematic Reviews
and Meta-Analysis Statement, 2009 (Additional file 1:
PRISMA Checklist) [17].
We systematically searched PubMed, Embase, and
Cochrane Library electronic databases (from database
inception to May 2014) for prospective studies in
humans that examined the relationship between alcohol
consumption and ovarian cancer; these studies were eli-
gible for inclusion in our study and no restrictions were
placed on language or publication status (published or in
press). Our core search included the following terms:
“ethanol” OR “alcohol” OR “alcoholic beverages” OR
“drinking behaviour” OR “alcohol drinking” OR “drink”
OR “liquor” OR “ethanol intake” OR “alcohol drink” OR
“ethanol drink” AND (“ovarian cancer” OR “ovarian neo-
plasm” OR “ovarian carcinoma” OR “ovary cancer” OR
“ovary neoplasm” OR “ovary carcinoma”) AND (“cohort”
OR “cohort studies”). If a site-specific dataset was pub-
lished more than once, we used the most recent publica-
tion. We reviewed the reference lists of the reports,
reviews, meta-analyses, and other relevant publications
to identify additional pertinent studies. The medical sub-
ject heading, methods, population, study design, expos-
ure, and outcome variables of these articles were used to
identify relevant studies.
A study was eligible for inclusion if the following cri-
teria were met: (1) the study had a prospective design
(prospective cohort or nested prospective case control
study), (2) the study investigated the association between
alcohol intake and the risk of ovarian cancer, and (3) the
authors reported effect estimates (risk ratio [RR] or haz-
ard ratio [HR]) and 95% confidence intervals (CIs) for
comparisons between individuals with high alcohol con-
sumption and individuals who did not consume alcohol.
We excluded all case–control studies because various
confounding factors could have biased the results.
The literature search was independently performed by
two authors using a standardized approach. Any incon-
sistencies were resolved through discussions with the
primary author to reach a consensus. We excluded stud-
ies that were not published as full reports, which in-
cluded conference abstracts and letters to the editor.
Data collection and quality assessment
The following information was collected: the first author
or study group name, publication year, country, studydesign, sample size, ovarian cancer cases, age at baseline,
effect estimate, follow-up duration, and covariates in the
fully adjusted model. For studies that reported several
multivariable adjusted RRs, we selected the effect esti-
mate that was adjusted for the maximum number of
potential confounders.
The Newcastle-Ottawa Scale (NOS) [18] was used to
evaluate the methodological quality. The NOS is a par-
tially validated comprehensive tool for evaluating the
quality of observational studies in meta-analyses [19]. It
is based on the following three subscales: selection
(4 items), comparability (1 item), and outcome (3 items).
A “star system” (range 0–9) was developed for assessment.
Two authors independently performed the data extraction
and quality assessment. Information was examined and
verified independently by an additional author.
Statistical analysis
We examined the relationship between alcohol intake
and risk of ovarian cancer on the basis of the effect esti-
mate (RR or HR) and the 95% CI published in each
study. We first used a fixed-effect model to calculate
summary RRs and 95% CIs for the different alcohol
intake levels and for non-drinkers. We then combined
the RRs for drinkers versus non-drinkers by using a
random-effect meta-analysis [20,21]. Heterogeneity be-
tween studies was investigated by using the Q statistic,
and we considered P-values < 0.10 to be indicative of sig-
nificant heterogeneity [22,23]. Subgroup analyses were
conducted for ovarian cancer on the basis of country,
type of alcohol consumption, duration of follow-up,
adjusted for oral contraceptive use or not, adjusted for
hormone replacement therapy or not, adjusted for meno-
pausal status or not, adjusted for smoking status or not,
adjusted for body mass index or not, and the NOS score.
We also performed a sensitivity analysis by removing
each study from the meta-analysis individually [24]. Sev-
eral methods were used to check for potential publica-
tion bias. Visual inspections of the funnel plots for
ovarian cancer were conducted. The Egger [25] and Begg
[26] tests were also used to statistically assess publica-
tion bias for ovarian cancer. All reported P-values were
two-sided and P-values < 0.05 were considered statisti-
cally significant for all studies. Statistical analyses were
performed using the STATA software (version 12.0; Stata
Corporation, College Station, TX, USA).
Results
The results of the study selection process are shown in
Figure 1. We identified 113 research articles in our ini-
tial electronic search, of which 81 were excluded because
they were irrelevant. A total of 32 potentially eligible
studies were then selected. After detailed evaluations, 13
prospective studies [14,15,27-37] were selected for the
Figure 1 Flow diagram of the literature search and studies selection process.
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lists of these studies did not yield any new eligible stud-
ies. The general characteristics of the included studies
are presented in Table 1 and Additional file 2: Table S1.
Of the 13 cohort studies that reported data from
1,996,841 individuals, the follow-up period for partici-
pants was 5.0–16.5 years and 22,550–1,280,296 individ-
uals were included in each study. Eight studies were
conducted in the U.S. [14,15,28-31,33,34], one in the UK
[27], one in Sweden [32], one in the Netherlands [35],
one in Canada [36], and one in Japan [37]. Study quality
was assessed using the NOS [18]. Here, we considered
a study with a score ≥ 7 to be of high quality. Overall,
two studies [29,31] had a score of 9, five studies
[14,27,32,35,36] had a score of 8, three studies [28,33,37]
had a score of 7, two studies [15,34] had a score of 6,
and one [30] had a score of 5.
An association between alcohol consumption and
ovarian cancer was reported in a total of 14 cohorts in
13 studies [14,15,27-37]. The summary RR showed that
alcohol consumption was not associated with ovarian
cancer (RR, 1.03; 95% CI, 0.96–1.10; P = 0.473; Figure 2)
but potential evidence of significant heterogeneity was
observed (P = 0.103). As a result, a sensitivity analysis was
conducted. Sequential exclusion of each individual study
from the pooled analysis demonstrated that the results
were not affected by the exclusion of any specific study.An association between low alcohol intake (<15 g/day)
and ovarian cancer was reported in a total of 13 cohorts
in 12 studies [14,15,27-36]. We also determined that low
alcohol intake was associated with a 4% reduced risk of
ovarian cancer, but this association was not statistically
significant (RR, 0.96; 95% CI, 0.93–1.00; P = 0.059;
Figure 3). Although no evidence of heterogeneity was
observed, we also conducted a sensitivity analysis and
concluded that low alcohol intake was not associated
with a reduced the risk of ovarian cancer (RR, 1.02;
95% CI, 0.94–1.11; P = 0.595; Figure 3).
An association between moderate alcohol intake (15–
30 g/day) and ovarian cancer was reported in a total of
13 cohorts in 12 studies [14,15,27-36]. The results from
a pooled analysis indicated that there was no association
between moderate alcohol intake and ovarian cancer
(RR, 1.08; 95% CI, 0.92–1.27; P = 0.333; Figure 4). Al-
though there was some evidence of heterogeneity across
the studies (P = 0.197), a sensitivity analysis indicated
that the results were not affected by sequential exclusion
of any individual study from the pooled analysis.
A total of 12 cohorts in 11 studies [14,15,27-31,33-37]
reported an association between heavy alcohol intake
(>30 g/d) and ovarian cancer. Overall, there was no sig-
nificant association between heavy alcohol intake and
ovarian cancer (RR, 0.99; 95% CI, 0.88–1.12; P = 0.904;
Figure 5). Although there was no heterogeneity was











Covariates in fully adjusted model NOS
score
ET Chang 2007 [15] US Cohort 90371 253 50.0 RR 8.1 Race, total energy intake, parity, oral
contraceptive use, strenuous exercise,
and menopausal status/HRT use; stratified
by age at baseline
6
NE Allen 2009 [27] UK Cohort 1280296 3559 55.9 RR 7.2 Age, region of residence, socioeconomic
status, BMI, smoking, physical activity,
use of oral contraceptives, and HRT
8
EV Bandera 1997 [28] US Cohort 22550 77 50-93 RR 7.0 Age, education, cigarettes/day, years
smoking, and total energy intake
7
ER Bertone 2002 (a) [29] US Cohort 80195 120 34-59 RR 16.0 Age, parity, age at menarche, menopausal
status/postmenopausal HRT used, tubal
ligation, and smoking status
9
ER Bertone 2002 (b) [29] US Cohort 59538 315 40-65 RR 16.0 Age, parity, age at menarche, menopausal
status/postmenopausal HRT used, tubal
ligation, and smoking status
9
EE Calle 2002 [30] US Cohort 60796 278 50-74 RR 5.0 Calendar year age at menarche,
menopausal status at baseline, oral
contraceptive use, HRT use among
postmenopausal women, parity, BMI,
smoking status, physical activity, and
energy intake
5
LE Kelemen 2004 [31] US Cohort 27205 147 55-69 RR 15.0 Age at menopause, physical activity,
postmenopausal HRT, oral contraceptive
use, family history of breast cancer,
family history of ovarian cancer, known
diabetes at baseline, smoking,
energy-adjusted intakes of total carotene,
vitamin C and vitamin E
9
JV Lacey 2002 [14] US Cohort 32885 142 40-93 RR 13.4 Age, menopause type, and oral
contraceptive use
8
SC Larsson 2004 [32] Sweden Cohort 61103 287 40-74 RR 10.5 Age, BMI, educational level, family history
of breast cancer, parity, age at first birth,
oral contraceptive use, age at menarche,
age at menopause, postmenopausal HRT,
fruit and vegetable, lactose, and total
energy intake.
8
J Lin 2004 [33] US Cohort 32466 104 45-89 RR 8.7 Age, random treatment assignment, BMI,
family history of colorectal cancer, history
of colorectal polyps, physical activity,
cigarette smoking, postmenopausal HRT,
and total energy intake
7
B Rockhill 1998 [34] US Cohort 91502 52 27-44 RR 6.0 Age at baseline, age at menarche, history
of benign breast disease, history of breast
cancer in mother and/or sister, height,
oral contraceptive history, and parity and
age at first birth
6
LJ Schouten 2004 [35] Netherland Cohort 62573 214 55-69 RR 9.3 Age, use of oral contraceptives, parity,
height, BMI, total energy intake, and
current cigarette smoking
8
PD Terry 2003 [36] Canada Cohort 49613 223 40-59 RR 16.5 Age in 5-year age groups, treatment
allocation, study centre, Quetelet’s index,
education level, vigorous physical activity,
oral contraceptive use, HRT, parity, age
of menarche, and menopausal status
8
E Weiderpass 2012 [37] Japan Cohort 45748 86 40-69 HR 16.0 Age, study center, age at menarche,
nulliparous, parity, age at first birth,
breastfeeding, use of exogenous hormones,
menopausal status, height, BMI, smoking
status, exposure to second-hand smoke,
physical activity, usual sleep duration,
family history of cancer
7
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Figure 2 Relative risk estimates of ovarian cancer for drinker versus non-drinker.
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analysis after excluding a study by Allen et al. [27].
These results indicated that heavy alcohol consump-
tion was associated with a 13% increased risk of
ovarian cancer. However, the increase was not statis-
tically significant (RR, 1.13; 95% CI, 0.90–1.41; P = 0.305;
Figure 5).
Heterogeneity testing revealed P > 0.10 for the incidence
of ovarian cancer. We conducted subgroup analyses for
ovarian cancer to minimize heterogeneity between the
studies and evaluated the association between alcohol in-
take and the risk of ovarian cancer in specific populationFigure 3 Relative risk estimates of ovarian cancer for low alcohol conor in studies with specific characteristics (Table 2). First,
we determined that alcohol consumption was associated
with a reduced risk of ovarian cancer if the individuals
were from other countries, the study was not adjusted for
menopausal status, and if the study was adjusted for
smoking status and body mass index. Furthermore, we
found that alcohol consumption was associated with an
increased risk of ovarian cancer if the study was not ad-
justed for smoking status. Second, low alcohol intake was
associated with a reduced risk of ovarian cancer if the par-
ticipants were from other countries, the follow-up dur-
ation was < 10 years, the study was adjusted for hormonesumption versus non-drinker.
Figure 4 Relative risk estimates of ovarian cancer for moderate alcohol consumption versus non-drinker.
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index, and the study was not adjusted for menopausal sta-
tus. Third, moderate alcohol consumption was associated
with an increased risk of ovarian cancer if the study was
adjusted for menopausal status but not for smoking status
and body mass index. Finally, heavy alcohol consumption
was associated with an increased risk of ovarian cancer ifFigure 5 Relative risk estimates of ovarian cancer for heavy alcohol cthe study was not adjusted for hormone replacement
therapy.
No funnel plot asymmetry was observed for the asso-
ciation between alcohol consumption and ovarian cancer
risk (Figure 6). The Egger [25] and Begg [26] tests
showed no evidence of publication bias for ovarian can-
cer (drinkers versus non-drinkers: P-value for the Eggeronsumption versus non-drinker.
Table 2 Subgroup analysis of ovarian cancer for alcohol intake versus nondrinker
Category Subgroup Number of cohorts RR and 95% CI P value P value for
heterogeneity test
Drinker versus nondrinker Country
US 9 1.05 (0.94-1.17) 0.428 0.126
Other 5 0.96 (0.92-0.99) 0.017 0.597
Type of alcohol intake
Wine 2 1.13 (0.92-1.38) 0.254 0.085
Beer 2 1.01 (0.86-1.18) 0.914 0.250
Liquor 2 1.02 (0.92-1.14) 0.652 0.789
Follow-up duration
More than 10 years 7 1.08 (0.98-1.19) 0.136 0.348
Less than 10 years 7 0.98 (0.91-1.06) 0.631 0.282
Adjusted oral contraceptive
Yes 9 1.05 (0.96-1.16) 0.262 0.038
No 5 0.98 (0.87-1.12) 0.797 0.506
Adjusted hormone replacement therapy
Yes 10 0.98 (0.94-1.03) 0.521 0.373
No 4 1.05 (0.81-1.37) 0.700 0.064
Adjusted menopausal status
Yes 8 1.08 (0.98-1.19) 0.140 0.219
No 6 0.95 (0.92-0.99) 0.009 0.674
Adjusted smoking status
Yes 9 0.96 (0.92-0.99) 0.011 0.716
No 5 1.14 (1.01-1.30) 0.036 0.285
Adjusted body mass index
Yes 6 0.96 (0.92-0.99) 0.010 0.890
No 8 1.07 (0.96-1.21) 0.226 0.139
NOS score
8 or 9 8 1.04 (0.95-1.14) 0.388 0.057
<8 6 1.01 (0.89-1.15) 0.859 0.368
Low alcohol intake versus nondrinker Country
US 9 1.01 (0.92-1.12) 0.803 0.665
Other 4 0.96 (0.92-1.00) 0.033 0.686
Follow-up duration
More than 10 years 6 1.06 (0.95-1.18) 0.315 0.595
Less than 10 years 7 0.95 (0.91-0.99) 0.017 0.957
Adjusted oral contraceptive
Yes 9 0.97 (0.93-1.00) 0.083 0.520
No 4 0.94 (0.80-1.09) 0.396 0.784
Adjusted hormone replacement therapy
Yes 9 0.96 (0.92-1.00) 0.039 0.871
No 4 1.06 (0.87-1.28) 0.584 0.335
Adjusted menopausal status
Yes 7 1.03 (0.93-1.13) 0.595 0.753
No 6 0.95 (0.92-0.99) 0.024 0.680
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Table 2 Subgroup analysis of ovarian cancer for alcohol intake versus nondrinker (Continued)
Adjusted smoking status
Yes 8 0.96 (0.92-0.99) 0.024 0.817
No 5 1.07 (0.94-1.22) 0.331 0.691
Adjusted body mass index
Yes 5 0.96 (0.92-0.99) 0.025 0.871
No 8 1.03 (0.93-1.15) 0.534 0.624
NOS score
8 or 9 8 0.98 (0.93-1.03) 0.408 0.391
<8 5 0.95 (0.82-1.10) 0.526 0.911
Moderate alcohol intake versus nondrinker Country
US 9 1.20 (0.95-1.52) 0.126 0.296
Other 4 0.97 (0.90-1.05) 0.440 0.858
Follow-up duration
More than 10 years 6 1.24 (0.97-1.60) 0.087 0.496
Less than 10 years 7 1.02 (0.83-1.25) 0.876 0.213
Adjusted oral contraceptive
Yes 9 1.06 (0.89-1.26) 0.537 0.239
No 4 1.15 (0.77-1.73) 0.500 0.281
Adjusted hormone replacement therapy
Yes 9 1.09 (0.92-1.30) 0.307 0.185
No 4 0.95 (0.51-1.74) 0.859 0.207
Adjusted menopausal status
Yes 7 1.31 (1.08-1.59) 0.007 0.538
No 6 0.96 (0.89-1.04) 0.323 0.785
Adjusted smoking status
Yes 8 0.98 (0.89-1.08) 0.662 0.412
No 5 1.37 (1.07-1.75) 0.012 0.734
Adjusted body mass index
Yes 5 0.97 (0.90-1.04) 0.370 0.938
No 8 1.26 (1.01-1.58) 0.037 0.344
NOS score
8 or 9 8 1.05 (0.89-1.23) 0.580 0.300
<8 5 1.08 (0.73-1.59) 0.713 0.249
Heavy alcohol intake versus nondrinker Country
US 9 1.04 (0.80-1.35) 0.758 0.605
Other 3 1.11 (0.79-1.56) 0.539 0.178
Follow-up duration
More than 10 years 5 1.07 (0.76-1.51) 0.691 0.339
Less than 10 years 7 0.98 (0.86-1.12) 0.757 0.517
Adjusted oral contraceptive
Yes 8 1.05 (0.87-1.27) 0.591 0.330
No 4 0.94 (0.62-1.44) 0.783 0.591
Adjusted hormone replacement therapy
Yes 8 0.96 (0.85-1.09) 0.536 0.814
No 4 1.76 (1.03-3.01) 0.038 0.655
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Table 2 Subgroup analysis of ovarian cancer for alcohol intake versus nondrinker (Continued)
Adjusted menopausal status
Yes 6 1.08 (0.83-1.40) 0.560 0.446
No 6 0.97 (0.84-1.11) 0.648 0.452
Adjusted smoking status
Yes 8 0.95 (0.83-1.08) 0.436 0.651
No 4 1.32 (0.94-1.84) 0.104 0.637
Adjusted body mass index
Yes 4 1.05 (0.77-1.43) 0.760 0.244
No 8 1.09 (0.84-1.41) 0.522 0.634
NOS score
8 or 9 7 1.04 (0.83-1.30) 0.721 0.277
<8 5 1.08 (0.76-1.54) 0.654 0.694
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intake versus non-drinkers: P-value for the Egger test:
0.160, P-value for the Begg test: 0.583; moderate alcohol
intake versus non-drinkers: P-value for the Egger test:
0.649, P-value for the Begg test: 0.246; heavy alcohol in-
take versus non-drinkers: P-value for the Egger test:
0.245, P-value for the Begg test: 0.837).
Discussion
This study was based on prospective studies, and it ex-
plored all possible correlations between alcohol con-
sumption and the risk of ovarian cancer. This large and
quantitative study included 1,996,841 individuals from
13 prospective cohort studies with a broad range of pop-
ulations. The findings from our meta-analysis suggest
that alcohol consumption has no effect on the incidence
of ovarian cancer. Furthermore, low, moderate, and
heavy alcohol consumption have no significant effects
on the risk of ovarian cancer.
A previous meta-analysis [16] based on observational
studies (case control and cohort) suggested that alcohol
consumption was not associated with the risk of ovarian
cancer. This previous review was inherently limited in
that the range of alcohol intake and the cut-off values
for the categories differed between studies. Additionally,
most studies were case control studies and various con-
founding factors could have biased the results. Finally,
several important factors considered leading risk factors
for ovarian cancer were not adjusted, and the subgroup
analyses of the previous meta-analysis [16] resulted in
no data regarding ovarian cancer caused by these factors.
Therefore, we conducted a meta-analysis of prospective
cohort studies to evaluate the association between alco-
hol intake and the risk of ovarian cancer.
Most of our findings were in agreement with a previ-
ous published pooled analysis of a cohort study con-
ducted in the U.S. [38]. This large, pooled analysisincluded 529,638 women and found that alcohol intake
was not associated with ovarian cancer risk. Further-
more, Chang et al. [15] suggested that alcohol intake
does not affect ovarian cancer risk, but women who con-
sumed at ≥1 glass of wine per day had an increased risk
of ovarian cancer. Our current study also indicated that
alcohol intake was not associated with the risk of ovarian
cancer. However, it might alter the risk of ovarian cancer
in specific populations or in studies with specific charac-
teristics. One possible explanation is that alcohol has
been shown to block the transport of folate to rapidly
proliferating tissues, resulting in impaired haematopoi-
esis [39]. Furthermore, the data on the different types of
alcohol consumed were rarely available. Therefore, we
cannot determine whether there is an association be-
tween any specific alcohol type and ovarian cancer risk.
We found that there was no significant association be-
tween alcohol consumption and the risk of ovarian can-
cer. However, several studies have reported inconsistent
results regarding the association. For example, Chang
et al. [15] suggested that moderate alcohol intake was
associated with a 47% (95% CI: 1.06–2.03) increase in
the risk of ovarian cancer. Similarly, Bertone et al. [28]
found that moderate alcohol consumption was associ-
ated with a 52% (95% CI: 1.01–2.29) increase in the risk
of ovarian cancer. Lacey et al. [14] reported that individ-
uals who consumed alcohol had an increased risk of
ovarian cancer compared to non-drinkers (RR, 1.43; 95%
CI: 1.09–1.88). Conversely, Allen et al. [27] suggested
that alcohol consumption might have a protective effect
on the risk of ovarian cancer (RR, 0.95; 95% CI: 0.92–
0.99). Moreover, low alcohol intake was associated with
a reduced risk of ovarian cancer (RR, 0.95; 95% CI:
0.91–0.99). The reasons for this discrepancy could be
the following: (1) the age at baseline in individual studies
might be an important confounding factor between alco-
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Figure 6 Funnel plot for ovarian cancer.
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licle stimulating and luteinizing hormones and gonado-
tropin levels, which might have an important effect on
the risk of ovarian cancer.
Subgroup analyses suggested that alcohol consumption
was associated with a reduction in ovarian cancer if the
individuals were from other countries, the study was not
adjusted for menopausal status, and if the study was ad-
justed for smoking status and body mass index. Specific-
ally, low alcohol intake was associated with a decreased
the risk of ovarian cancer if the participants were from
other countries, the follow-up duration was < 10 years,the study was adjusted for hormone replacement ther-
apy, smoking status, and body mass index, and if the
study was not adjusted for menopausal status. In con-
trast, we determined that alcohol consumption was asso-
ciated with an increased risk of ovarian cancer if the
study was not adjusted for smoking status. Moderate al-
cohol intake was associated with an increased risk of
ovarian cancer if the study was adjusted for menopausal
status and if the study was not adjusted for smoking status
and body mass index. Finally, heavy alcohol intake was as-
sociated with an increased risk of ovarian cancer if the
study was not adjusted for hormone replacement therapy.
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tiple interrelations between alcohol intake and country,
or by the duration of the follow-up, menopausal status,
smoking status, and body mass index. However, we
could not determine the effects of the confounding fac-
tors on the risk of ovarian cancer because few studies
were stratified by these important factors. The duration
of alcohol intake was another important factor that was
rarely reported in these studies. Therefore, we provided
a relative result and a synthetic and comprehensive
review.
The limitations of our study are the following: (1) the
adjusted models differ between studies and these factors
might play an important role in the development of
ovarian cancer, (2) publication bias in a meta-analysis of
published studies is an inevitable problem, and (3) the
analysis was performed using pooled data because indi-
vidual data were not available, which restricted us from
performing a more detailed analysis in order to obtain
more comprehensive results.Conclusions
The results of this study suggest that alcohol consump-
tion is not associated with ovarian cancer risk. Subgroup
analyses indicated that low or moderate alcohol con-
sumption could be associated with the risk of ovarian
cancer in specific populations or in studies with specific
characteristics. Future studies should focus on specific
populations for primary analysis of ovarian cancer
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